$23.97
-0.24 (-0.99%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+87.6% upside
Low Target
$33.78
Average Target
$44.96
High Target
$58.81
Current Price
$23.97
Current
$23.97
$23.97
Target
$44.96
$44.96
$33.78
$44.96 avg
$58.81
Scenario Analysis
Bear Case
$33.78
40.9%
Low target
Base Case
$44.96
+87.6%
Avg target
Bull Case
$58.81
+145.3%
High target
Risk/Reward
3.6x
Highly favorable
Price in Context
52-Week High
$31.37
-23.6% from high
52-Week Low
$4.66
+414.4% from low
Target vs 52W High
$44.96
+43.3% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |